Aquis Exchange to add Czech and Hungarian Stocks

RNS Number : 9222D
Aquis Exchange PLC
08 March 2022
 

8 March 2022

Aquis Exchange PLC

("Aquis" or the "Group")

Aquis Exchange to add Czech and Hungarian Stocks

Expansion brings total number of markets covered to 17

 

Aquis Exchange PLC (AQX.L), the exchange services group, is to add Czech and Hungarian blue-chip stocks to trading on its pan-European MTFs business, Aquis Exchange.

During the second quarter of 2022, some 300 additional stocks will be made available for trading on the Aquis Exchange UK and Aquis Exchange EU platforms, including the 13 largest, most liquid, Czech and Hungarian stocks. The expansion of the Aquis Exchange trading universe by the addition of Czech and Hungarian stocks brings the total number of markets covered by the exchange to 17.

Commenting on the announcement, Alasdair Haynes, CEO of Aquis Exchange, said:

"Our policy has always been to add new markets to our platform as and when there is demand. Member appetite for investing in Czech and Hungarian blue-chip stocks is growing and we are responding to this trend."

Enquiries:

Aquis Exchange PLC via




Alma PR (Financial PR Adviser)

Tel: +44 (0)20 3405 0209

Susie Hudson

aquis@almapr.co.uk

Kieran Breheny 


Matthew Young






Liberum Capital Limited (Nominated Adviser and Joint Broker)

Tel: +44 (0) 20 3100 2000

Chris Clarke


Clayton Bush


Edward Thomas


Kane Collings




Canaccord Genuity Limited (Joint Broker)

Tel: +44 (0) 20 7523 8000

Bobbie Hilliam


Patrick Dolaghan


 

Notes to Editors

About Aquis Exchange PLC

Aquis Exchange PLC is an exchange services group, which operates pan-European cash equities trading businesses (Aquis Exchange), growth and regulated primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange software to third parties (Aquis Technologies).

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK/Switzerland and in EU27 respectively. Aquis operates lit order books and does not allow aggressive non-client proprietary trading, which has resulted in lower market impact and signalling risk on Aquis than other trading venues in Europe. According to independent studies, trades on Aquis are less likely to lead to price movement than on other lit markets. Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with different levels of admission criteria. The Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

Aquis Exchange PLC (AQX.L) is listed on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to www.aquis.eu .

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABLGDXLUGDGDR
UK 100

Latest directors dealings